920 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
6 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
7 Recruiting Study of Consolidation Chemotherapy For Bulky Local Advanced None-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: consolidation chemotherapy of AP or DP after CCRT
8 Not yet recruiting Anti-PD-L1 in Stage IIIA(N2) NSCLC
Condition: NSCLC Non-small Cell Lung Cancer
Intervention: Drug: MEDI4736 (anti-PD-L1)
9 Not yet recruiting A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies
Conditions: Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma;   Non-Small Cell Lung Cancer;   Hepatocellular Carcinoma
Interventions: Drug: Ramucirumab;   Drug: MEDI4736
10 Not yet recruiting Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors
Conditions: Non-small Cell Lung Cancer;   Thoracic Surgery
Intervention: Drug: Indocyanine Green
11 Not yet recruiting The Use of Systematically Injected Indocyanine Green in Robotic Segmentectomy
Condition: Non-small Cell Lung Cancer
Intervention: Drug: indocyanine green
12 Recruiting Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Docetaxel;   Drug: Paclitaxel;   Radiation: stereotactic radiosurgery
13 Not yet recruiting BIO 300 Non-Small Cell Lung Cancer Study
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIO 300 Oral Suspension;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy
14 Not yet recruiting Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Conditions: Estrogen Receptor Negative;   Head and Neck Squamous Cell Carcinoma;   HER2/Neu Negative;   Hormone-Resistant Prostate Cancer;   Metastatic Pancreatic Adenocarcinoma;   Progesterone Receptor Negative;   Solid Neoplasm;   Stage III Mesothelioma;   Stage IIIA Gastric Cancer;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Small Cell Lung Carcinoma;   Stage IIIB Gastric Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Small Cell Lung Carcinoma;   Stage IIIC Gastric Cancer;   Stage IIIC Ovarian Cancer;   Stage IV Mesothelioma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Ovarian Cancer;   Stage IV Small Cell Lung Carcinoma;   Triple-Negative Breast Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Talazoparib
15 Not yet recruiting Clinical Trial of Lurbinectedin (PM01183) Plus Doxorubicin (DOX) Versus Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line
Condition: Small-cell Lung Cancer
Interventions: Drug: Lurbinectedin (PM01183);   Drug: Doxorubicin;   Drug: Topotecan
16 Not yet recruiting Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
Conditions: Metastatic Neoplasm;   Recurrent Neoplasm;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Unresectable Malignant Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Targeted Therapy
17 Not yet recruiting Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)
Condition: Metastatic Squamous Non-small Cell Lung Cancer
Interventions: Drug: Pembrolizumab;   Drug: Placebo
18 Not yet recruiting Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Conditions: Non-small Cell Lung Cancer;   Gastric Cancer;   Hepatocellular Carcinoma;   Colorectal Cancer
Intervention: Biological: natural killer T cell
19 Not yet recruiting SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
Conditions: Carcinoma, Non-Small-Cell-Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer
Interventions: Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30;   Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13;   Behavioral: Modified Medical Research Council;   Behavioral: EQ-5D;   Behavioral: Center for Epidemiological Studies Depression Scale;   Behavioral: Medical Outcomes Study Social Support Survey
20 Recruiting Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Condition: Non-Small Cell Lung Carcinoma (NSCLC)
Intervention: Other: Survey

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years